23. Juni 2026 | Fachveröffentlichungen
An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.
An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.
P A Costa G, Sofuoglu M, Compton P, Ranganathan M, Pittman B, De Aquin…